The value of FDG-PET in the follow-up of differentiated thyroid cancer: a review of the literature

被引:0
|
作者
Stokkel, MPM [1 ]
Duchateau, CSJ [1 ]
Dragoiescu, C [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Nucl Med, NL-2300 RC Leiden, Netherlands
关键词
thyroideal neoplasms; fluodeoxyglucose; F18; tomography; emission computed;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Well differentiated (follicular and papillary) thyroid cancer (DTC) is characterized by rare occurrence and a good prognosis. However, up to 20% of patients with DTC develop locoregional. recurrences, whereas even 8% of patients with such recurrences will eventually die from disease. In some of these patients it is related to incomplete initial treatment, whereas in others it indicates the presence of an aggressive tumor. in this latter case, dedifferentiation may occur with negative I-131 whole body scintigraphy (WBS) results and unreliable Tg measurements. In patients with thyroid cancer metastases that lost the capability of I-131 uptake, other imaging techniques are required to depict the nonfunctioning metastases, irrespective of the Tg-levels and irrespective of the site of recurrent disease. In this respect, some reports have discussed the value of ultrasonography of the head and neck region with good results for the detection of locoregional disease. We have assessed the role of FDG-PET in patients with I-131 negative WBS and its relation with Tg values and TSH-stimulation based on data that have appeared in the literature. In this review article, a discussion is given on the results published so far.
引用
收藏
页码:78 / 87
页数:10
相关论文
共 50 条
  • [1] FDG-PET in the follow-up of differentiated thyroid cancer.
    Grunwald, F
    Menzel, C
    Bender, H
    Palmedo, H
    Klemm, E
    Ruhlmann, J
    Biersack, HJ
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 527 - 527
  • [2] Delayed acquisition in FDG-PET used for follow-up and staging of differentiated thyroid cancer
    Zaplatnikov, K.
    Menzel, C.
    Doebert, N.
    Diehl, M.
    Hamscho, N.
    Gruenwald, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S157 - S157
  • [3] FDG PET in the follow-up of patients with differentiated thyroid cancer
    Szakall, S
    Ésik, O
    Emri, M
    Füzy, M
    Tóth, E
    Forrai, G
    Trón, L
    RADIOACTIVE ISOTOPES IN CLINICAL MEDICINE AND RESEARCH XXIII, 1999, : 475 - 478
  • [4] FDG-PET, I-131 and MIBI scintigraphy in the follow-up of differentiated thyroid cancer
    Grunwald, F
    Biersack, HJ
    Klemm, E
    Menzel, C
    Bender, H
    Bultmann, T
    Schomburg, A
    Ruhlmann, J
    Palmedo, H
    RADIOACTIVE ISOTOPES IN CLINICAL MEDICINE AND RESEARCH, 1997, : 63 - 68
  • [5] PET in the follow-up of differentiated thyroid cancer
    Khan, N
    Oriuchi, N
    Higuchi, T
    Zhang, H
    Endo, K
    BRITISH JOURNAL OF RADIOLOGY, 2003, 76 (910): : 690 - 695
  • [6] The usefulness of FDG PET/CT in the routine follow-up of differentiated thyroid cancer
    Lee, H.
    Lee, S.
    Hong, C.
    Song, B.
    Kang, S.
    Jeong, S.
    Ahn, B.
    Lee, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S412 - S413
  • [7] The role of FDG PET/CT in the follow-up of patients with differentiated thyroid cancer and medullary thyroid cancer
    Valotassiou, V.
    Laspas, F.
    Malamitsi, J.
    Gogou, L.
    Kaldrimidis, P.
    Kehagias, D.
    Andreou, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S191 - S191
  • [8] Follow-up of differentiated thyroid cancer: What is the value of FDG and sestamibi in the diagnostic algorithm?
    Dietlein, M
    Scheidhauer, K
    Voth, E
    Theissen, P
    Schicha, H
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 1998, 37 (01): : 6 - 11
  • [9] The Value of Subsequent FDG-PET in Head and Neck Cancer Follow-up after a Negative Post-radiotherapy FDG-PET
    Yao, M.
    Lu, M.
    Savvides, P.
    Rezaee, R.
    Zender, C.
    Bualti, J.
    Machtay, M.
    Lavertu, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S499 - S499
  • [10] Additional value of FDG-PET in evaluating follow-up patients with esophageal cancer.
    Nakamoto, Y
    Saga, T
    Ishimori, T
    Higashi, T
    Mamede, M
    Imamura, M
    Sakahara, H
    Konishi, J
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 78P - 78P